Skip to content
Screener

Core Scientific, Inc. CORZ Total Liabilities & Equity

Total Liabilities & Equity at other companies

CleanSpark logo
CleanSparkCLSK
$2.7B-12.9%
TeraWulf logo
TeraWulfWULF
$8.05B+826%
Equinix, Inc. logo
Equinix, Inc.EQIX
$41.08B+5.7%
Applied Digital logo
Applied DigitalAPLD
$9.93B+431%
Digital Realty logo
Digital RealtyDLR
$49.41B+9.1%
Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
$4.35B-43.7%

Other financials

Income statement

See full
Revenue$164.2M+109%
Gross profit$70.0M+1,294%
Operating income-$78.5M-199%
Net income-$1.2B-23.3%
EPS (diluted)-$3.32-8,200%

Balance sheet

See full
Cash & equivalents$2.6B+339%
Total debt$4.4B+279%
Total equity-$2.4B-127%
Total assets$5.3B+166%

Cash flow

See full
Operating cash flow$249.9M+715%
CapEx$565.0M+366%
Free cash flow-$583.9M-569%

Valuation

See full
Market cap$7B+63.3%
Enterprise value$8.85B+81.9%
P/S15.9×+3.6×

Profitability

See full
Gross margin28.3%+23.2pp
Operating margin-128.5%-362pp
Net margin-237.6%-3.1pp
FCF margin-217.5%-446pp

Returns & leverage

See full
Return on equity148.5%
Debt / equity2.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 7:08 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001839341-26-000014
Line itemJune 30,2026December 31,2025
Commitments and contingencies (Note 10)
Stockholders’ Deficit:
Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025
Common stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively33
Additional paid-in capital3,229,8423,183,960
Accumulated deficit(5,649,201)(4,146,703)
Total Stockholders’ Deficit(2,419,356)(962,740)
Total Liabilities and Stockholders’ Deficit$5,257,493$2,347,644

Item 1. Financial Statements (Unaudited)

FAQ

What is Core Scientific, Inc.'s total liabilities & equity?
Core Scientific, Inc. (CORZ) reported total liabilities & equity of $5.26B in Q2 2026.
How has Core Scientific, Inc.'s total liabilities & equity changed year-over-year?
Core Scientific, Inc.'s total liabilities & equity increased by 165.8% year-over-year, from $1.98B to $5.26B.
What is the long-term trend for Core Scientific, Inc.'s total liabilities & equity?
Over 5 years (2020 to 2025), Core Scientific, Inc.'s total liabilities & equity has grown at a 993.7% compound annual growth rate (CAGR), from $15K to $2.35B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Core Scientific, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude